Kainos Medicine
Scope
Date
~
-
Bio & Pharma
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Feb 27, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...
Aug 21, 2024 (Gmt+09:00)
-
Healthcare
Korea’s booming medical tourism: Skin care, plastic surgery in demand
The number of foreign patients visiting South Korea for medical tourism hit a record high last year, driven by those who traveled to Korea for skin ...
Apr 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong gets stem cell facility license in Indonesia
South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational...
Feb 13, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets FDA OK for its interchangeable biosimilar
Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...
Oct 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's GER drug gets product OK from Mexico
South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...
Oct 19, 2023 (Gmt+09:00)
-
Korean food
Gluten-free Korean snack, pea soy sauce lure European gourmets
COLOGNE, Germany – The traditional Korean snack yakgwa and a soy-like sauce made with peas were named innovative foods of the year at the worl...
Oct 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Moderna signs mRNA access deals with S.Korea's universities
The US biotech and pharmaceutical company Moderna on Friday announced signings of contracts with the academic-industry cooperation foundations of Ko...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on prescription of 10 private US insurers
South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...
Aug 23, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience buys 6.5 million Novavax shares for $83.4 million
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...
Aug 09, 2023 (Gmt+09:00)
-
Logistics
CJ Logistics to enter global pharmaceutical transportation market
South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada
South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...
Jul 12, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Blackstone seeks medicine distributor sale for 1st Korea exit
Blackstone Inc. has embarked on the process of selling South Korea’s largest medicine wholesaler Geo-Young Corp., a deal estimated at up to $1...
Jul 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $897 mn in two deals with Pfizer
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...
Jul 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Osteonic starts sports medicine exports to Japan
South Korea's surgical and medical instruments maker Osteonic Co. on Thursday announced the start of exports of its Kinex sports medicine products t...
May 19, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey
South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Celltrion Healthcare launches Vegzelma in US
South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...
Apr 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs, Kakao Healthcare to explore microbiome-based precision medicine solutions
Kobiolabs Co., South Korea's new drug development company for microbiomes, announced on Tuesday that it has signed a memorandum of understanding for...
Mar 29, 2023 (Gmt+09:00)
-
Bio & Pharma
CGBio inks export deal for hyaluronic acid fillers with Chinese distributor
CGBio, a South Korean bio-regenerative medical company, has signed an export deal with Shanghai Feiting Trading Co., a Chinese medical device distri...
Mar 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung, Axiom Space to set up JV to explore space healthcare options
South Korea's Boryung Corp., just decades ago a mom-and-pop pharmacy, will bring its healthcare expertise to space with Axiom Space Inc., a US comme...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem mulls shuttering in-vitro diagnostics business
LG Chem Ltd. is considering an exit from the in-vitro diagnostics market to focus more on novel drug development as it lagged its smaller local riva...
Mar 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Novel medicines poised to be Korea’s next mainstay export
South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Ybrain, Chong Kun Dang join forces for digital medicine distribution
South Korean electroceutical platform company Ybrain Inc. said on Tuesday it has entered into a joint promotion agreement with Chong Kun Dang Pharma...
Jan 31, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand